PMHNP Exam | complete exam with
correct verified answers for guaranteed
success.
A 28-year-old patient with major depressive disorder
reports new-onset agitation, diaphoresis, tremor, and
hyperreflexia after starting an MAOI and an SSRI a week
ago. The nurse recognizes this combination most likely
produced:
a) Neuroleptic malignant syndrome
b) Serotonin syndrome
c) Anticholinergic toxicity
d) Hypertensive crisis
Correct answer: b) Serotonin syndrome
,A patient stabilized on lithium has serum lithium level 0.9
mEq/L and develops nausea, coarse tremor, and confusion
after starting a thiazide diuretic. The clinician should:
a) Ignore — levels are therapeutic
b) Anticipate decreased lithium levels with thiazides
c) Check lithium level and consider lowering lithium dose or
stopping the thiazide
d) Increase lithium dose to compensate
Correct answer: c) Check lithium level and consider
lowering lithium dose or stopping the thiazide
A patient with bipolar I disorder is started on valproate.
Which baseline labs are most important prior to initiation?
a) Fasting glucose and hemoglobin A1c
b) Liver function tests and platelet count
,c) Serum potassium and magnesium
d) Thyroid function tests only
Correct answer: b) Liver function tests and platelet count
A 45-year-old with schizophrenia is switched from
haloperidol to a second-generation antipsychotic. Which
adverse effect is most important to monitor long term?
a) Nephrotoxicity
b) Metabolic syndrome (weight, lipids, glucose)
c) Ototoxicity
d) Visual field loss
Correct answer: b) Metabolic syndrome (weight, lipids,
glucose)
A patient taking clozapine calls reporting fever, sore throat,
and malaise. The nurse’s priority is to:
, a) Reassure — common side effect
b) Check an immediate complete blood count (CBC) to
evaluate for agranulocytosis
c) Suggest over-the-counter antipyretics and continue
medication
d) Advise adding a second antipsychotic temporarily
Correct answer: b) Check an immediate complete blood
count (CBC) to evaluate for agranulocytosis
Which antidepressant is safest in a patient with significant
cardiac conduction abnormalities?
a) Tricyclic antidepressants (e.g., amitriptyline)
b) MAO inhibitors (e.g., phenelzine)
c) SSRIs (e.g., sertraline) — generally preferred due to
better cardiac safety profile